<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Cancer Urology</journal-id><journal-title-group><journal-title xml:lang="en">Cancer Urology</journal-title><trans-title-group xml:lang="ru"><trans-title>Онкоурология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1726-9776</issn><issn publication-format="electronic">1996-1812</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1090</article-id><article-id pub-id-type="doi">10.17650/1726-9776-2007-3-1-65-68</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ДИАГНОСТИКА И ЛЕЧЕНИЕ ОПУХОЛЕЙ МОЧЕПОЛОВОЙ СИСТЕМЫ. Рак предстательной железы</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Expression of human interleukin-6 and its viral homologue in prostate cancer tissue</article-title><trans-title-group xml:lang="ru"><trans-title>Экспрессия интерлейкина-6 человека и его вирусного гомолога в ткани рака предстательной железы</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Veliyev</surname><given-names>Yе. I.</given-names></name><name xml:lang="ru"><surname>Велиев</surname><given-names>Е. И.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Department of Urology and Surgical Andrology</p></bio><bio xml:lang="ru"><p>Кафедра урологии и хирургической андрологии</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Rybalchenko</surname><given-names>A. V.</given-names></name><name xml:lang="ru"><surname>Рыбальченко</surname><given-names>А. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Department of Urology and Surgical Andrology</p></bio><bio xml:lang="ru"><p>Кафедра урологии и хирургической андрологии</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shirokov</surname><given-names>D. A.</given-names></name><name xml:lang="ru"><surname>Широков</surname><given-names>Д. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Laboratory of Immunology of Hemopoiesis</p></bio><bio xml:lang="ru"><p>Лаборатория иммунологии гемопоэза</p></bio><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Tupitsyn</surname><given-names>N. N.</given-names></name><name xml:lang="ru"><surname>Тупицын</surname><given-names>Н. Н.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Laboratory of Immunology of Hemopoiesis</p></bio><bio xml:lang="ru"><p>Лаборатория иммунологии гемопоэза</p></bio><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Russian Medical Academy of Postgraduate Education</institution></aff><aff><institution xml:lang="ru">РМАПО</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences</institution></aff><aff><institution xml:lang="ru">ГУ РОНЦ им. Н.Н.Блохина РАМН</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2007-03-30" publication-format="electronic"><day>30</day><month>03</month><year>2007</year></pub-date><volume>3</volume><issue>1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>65</fpage><lpage>68</lpage><history><date date-type="received" iso-8601-date="2020-02-15"><day>15</day><month>02</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-02-15"><day>15</day><month>02</month><year>2020</year></date></history><permissions><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://oncourology.abvpress.ru/oncur/article/view/1090">https://oncourology.abvpress.ru/oncur/article/view/1090</self-uri><abstract xml:lang="en"><p>Human interleukin-6 (IL-6) is of considerable importance in the pathogenesis of prostate cancer (PC). Prostatic cells are also known to be a reservoir for human herpesvirus 8 type (HHV-8). Due to the findings that HHV-8 had a homologue of human IL-6, viral IL-6, it seemed interesting to study the expression of these two cytokines in the tumor tissue of patients with PC. The expression of IL-6 mRNA was found in 70% of the patients. That of viral IL-6 was not detected in this disease. Nevertheless, a genetic HHV-8 material was ascertained in the tumor tissue of 2 patients with PC.</p></abstract><trans-abstract xml:lang="ru"><p>.</p></trans-abstract><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Siegall C.B., Schwab G., Nordan R.P. et al. Expression of the interleukin 6 receptor and interleukin 6 in prostate carcinoma cells. Cancer Res 1990;50(24):7786—8.</mixed-citation><mixed-citation xml:lang="ru">Siegall C.B., Schwab G., Nordan R.P. et al. Expression of the interleukin 6 receptor and interleukin 6 in prostate carcinoma cells. Cancer Res 1990;50(24):7786—8.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Siegsmund M.J., Yamazaki H., Pastan I. Inreleukin 6 receptor mRNA in prostate carcinomas and benign prostatic hyperplasia. J Urol 1994;151(5):1396—9.</mixed-citation><mixed-citation xml:lang="ru">Siegsmund M.J., Yamazaki H., Pastan I. Inreleukin 6 receptor mRNA in prostate carcinomas and benign prostatic hyperplasia. J Urol 1994;151(5):1396—9.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Palmer J., Hertzog P.J., Hammacher A. Differential expression and effects of gp130 cytokines and receptors in prostate cancer cells. Int J Biochem 2004;36(11):2258—69.</mixed-citation><mixed-citation xml:lang="ru">Palmer J., Hertzog P.J., Hammacher A. Differential expression and effects of gp130 cytokines and receptors in prostate cancer cells. Int J Biochem 2004;36(11):2258—69.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Kim O., Jiang T., Xie Y. et al. Synergism of cytoplasmic kinases in IL6-induced ligandindependent activation of androgen receptor in prostate cancer cells. Oncogene 2004;23(10):1838—44.</mixed-citation><mixed-citation xml:lang="ru">Kim O., Jiang T., Xie Y. et al. Synergism of cytoplasmic kinases in IL6-induced ligandindependent activation of androgen receptor in prostate cancer cells. Oncogene 2004;23(10):1838—44.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. Hammacher A., Thompson E.W., Williams E.D. Interleukin-6 is a potent inducer of S100P, which is upregulated in andoreg-refactory and metastatic prostate cancer. Int J Biochem 2005;37(2):442—50.</mixed-citation><mixed-citation xml:lang="ru">Hammacher A., Thompson E.W., Williams E.D. Interleukin-6 is a potent inducer of S100P, which is upregulated in andoreg-refactory and metastatic prostate cancer. Int J Biochem 2005;37(2):442—50.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. Гурцевич В.Э. Вирус герпеса человека 8 типа (HHV-8). В кн.: Канцерогенез. Под ред. Д.Г. Заридзе. М., Медицина; 2004. с.314—25.</mixed-citation><mixed-citation xml:lang="ru">Гурцевич В.Э. Вирус герпеса человека 8 типа (HHV-8). В кн.: Канцерогенез. Под ред. Д.Г. Заридзе. М., Медицина; 2004. с.314—25.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7. Гурцевич В.Э., Кадырова Е.Л., Чернова В.А. и др. Поиск резервуара для HHV-8-ассоциированных болезней и путей распространения HHV-8 в России. Вопр вирусол 2004;49(6):20—4.</mixed-citation><mixed-citation xml:lang="ru">Гурцевич В.Э., Кадырова Е.Л., Чернова В.А. и др. Поиск резервуара для HHV-8-ассоциированных болезней и путей распространения HHV-8 в России. Вопр вирусол 2004;49(6):20—4.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8. Hoffman L.J., Bunker C.H., Pellett P.E. et al. Elevated seroprevalence of human herpesvirus 8 among men with prostate cancer. J Infect Dis 2004;189(1):15—20.</mixed-citation><mixed-citation xml:lang="ru">Hoffman L.J., Bunker C.H., Pellett P.E. et al. Elevated seroprevalence of human herpesvirus 8 among men with prostate cancer. J Infect Dis 2004;189(1):15—20.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
